Kuppusamy Karthik's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Mar 6, 2026
- Accession no.
- 0001022079-26-000025
- Filed
- Mar 6, 2026
- Trade date
- Mar 4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $538.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kuppusamy KarthikCIK 0001955217 | Officer (SVP, Clinical Solutions) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Common Stock | AGrant or awardAcquired | +6,200 | $204.86 | +$1,270,132 | 16,069 | Direct | |
| Mar 4, 2026 | Common Stock | SSaleDisposed | −2,628 | $204.86 | −$538,372.08 | 13,441 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.